دورية أكاديمية
أعرض في EDS

Cannabinoid CB 2 receptor agonist reduces local and systemic inflammation associated with pneumonia-induced sepsis in mice.

التفاصيل البيبلوغرافية
العنوان: Cannabinoid CB 2 receptor agonist reduces local and systemic inflammation associated with pneumonia-induced sepsis in mice.
المؤلفون: Souza CF; Department of Pharmacology, Federal University of Santa Catarina, SC, Brazil., Borges LB; Department of Pharmacology, Federal University of Santa Catarina, SC, Brazil., Oliveira FRMB; Department of Pharmacology, Federal University of Santa Catarina, SC, Brazil., Silva PCS; Department of Microbiology, Immunology anda Parasitology, Federal University of Santa Catarina, SC, Brazil., Patricio DO; Department of Microbiology, Immunology anda Parasitology, Federal University of Santa Catarina, SC, Brazil., Rosales TO; Department of Pharmacology, Federal University of Santa Catarina, SC, Brazil., Souza NF; Department of Pharmacology, Federal University of Santa Catarina, SC, Brazil., Spiller F; Department of Pharmacology, Federal University of Santa Catarina, SC, Brazil., Mansur DS; Department of Microbiology, Immunology anda Parasitology, Federal University of Santa Catarina, SC, Brazil., Assreuy J; Department of Pharmacology, Federal University of Santa Catarina, SC, Brazil., Sordi R; Department of Pharmacology, Federal University of Santa Catarina, SC, Brazil. Electronic address: r.sordi@ufsc.br.
المصدر: European journal of pharmacology [Eur J Pharmacol] 2023 Nov 15; Vol. 959, pp. 176092. Date of Electronic Publication: 2023 Oct 04.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2005- : Amsterdam : Elsevier Science
Original Publication: Amsterdam, North Holland Pub. Co.
مواضيع طبية MeSH: Pneumonia*/drug therapy , Cannabinoids*/pharmacology , Sepsis*/complications , Sepsis*/drug therapy , Sepsis*/metabolism, Female ; Mice ; Male ; Animals ; Cannabinoid Receptor Agonists/pharmacology ; Inflammation/drug therapy ; Inflammation/metabolism ; Receptors, Cannabinoid ; Receptor, Cannabinoid, CB2 ; Receptor, Cannabinoid, CB1
مستخلص: Sepsis is a severe condition secondary to dysregulated host response to infection leading to tissue damage and organ dysfunction. Cannabinoid CB 2 receptor has modulatory effects on the immune response. Therefore, this study investigated the effects of a cannabinoid CB 2 receptor agonist on the local and systemic inflammatory process associated with pneumonia-induced sepsis. Pneumonia-induced sepsis was induced in mice by intratracheal inoculation of Klebsiella pneumoniae. Tissue and bronchoalveolar lavage (BAL) were collected 6, 24, or 48 h after surgery. Mice were treated with CB 2 agonist (AM1241, 0.3 and 3 mg/kg, i.p.) and several parameters of inflammation were evaluated 24 h after sepsis induction. Polymorphonuclear cell migration to the infectious focus peaked 24 h after pneumonia-induced sepsis induction in male and female animals. Septic male mice presented a significant reduction of cannabinoid CB 2 receptor density in the lung tissue after 24 h, which was not observed in females. CB 2 expression in BAL macrophages was also reduced in septic animals. Treatment of septic mice with AM1241 reduced cell migration, local infection, myeloperoxidase activity, protein extravasation, and NOS-2 expression in the lungs. In addition, the treatment reduced plasma IL-1β, increased IL-10 and reduced the severity and mortality of septic animals. These results suggest that AM1241 promotes an interesting balance in the inflammatory response, maintaining lung function and preventing organ injury. Therefore, cannabinoid CB 2 receptors are potential targets to control the excessive inflammatory process that occurs in severe conditions, and agonists of these receptors can be considered promising adjuvants in pneumonia-induced sepsis treatment.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier B.V. All rights reserved.)
فهرسة مساهمة: Keywords: AM1241; Endocannabinoid system; Nitric oxide synthase; Pulmonary infection; Sepsis; Sex difference
المشرفين على المادة: 0 (Cannabinoid Receptor Agonists)
0 (AM 1241)
0 (Cannabinoids)
0 (Receptors, Cannabinoid)
0 (Receptor, Cannabinoid, CB2)
0 (Receptor, Cannabinoid, CB1)
تواريخ الأحداث: Date Created: 20231005 Date Completed: 20231027 Latest Revision: 20231027
رمز التحديث: 20231215
DOI: 10.1016/j.ejphar.2023.176092
PMID: 37797676
قاعدة البيانات: MEDLINE
الوصف
تدمد:1879-0712
DOI:10.1016/j.ejphar.2023.176092